An Open-Label, Randomized, Parallel-Group Study to Evaluate the Acute and Steady-State Renal Hemodynamic Responses to Aliskiren in Patients With Type 2 Diabetes Mellitus.
Phase of Trial: Phase IV
Latest Information Update: 28 Aug 2012
At a glance
- Drugs Aliskiren; Captopril; Irbesartan
- Indications Hypertension
- Focus Pharmacodynamics
- Sponsors Novartis
- 31 Aug 2018 Biomarkers information updated
- 28 Apr 2010 Actual patient number (45) added as reported by ClinicalTrials.gov.
- 28 Apr 2010 Actual end date (Dec 2009) added as reported by ClinicalTrials.gov.